Na, Xueqing
Chen, Ying
Liu, Xin
Yang, Jian
Tan, Miao
Zhou, Yun
Shi, Man
Ouyang, Jie
Si, Yongyu
Funding for this research was provided by:
Wu Jieping Medical Foundation
Article History
Received: 23 August 2025
Accepted: 2 February 2026
First Online: 13 February 2026
Declarations
:
: This prospective, randomized, controlled study was approved by the Medical Ethics Committee of the Second Affiliated Hospital of Kunming Medical University (original approval No. PJ-PJ‑Ke‑2024‑292) and conducted in accordance with the principles of the Declaration of Helsinki. Prior to the initiation of the study, the protocol underwent an amendment, which was approved under No. YJ‑2025‑373. The trial was prospectively registered in the Chinese Clinical Trial Registry (ChiCTR) on 5 February 2025 (registration identifier: ChiCTR2500096716). Written informed consent was obtained from all included patients.
: Not applicable.
: The authors declare no competing interests.